HCV INHIBITING MACROCYCLIC PHENYLCARBAMATES

HCV INHIBITING MACROCYCLIC PHENYLCARBAMATES

Compounds of the Formula (I) including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof;usefulas HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising thes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANTONOV, DMITRY, SAMUELSSON, BENGT, BERTIL, RABOISSON, PIERRE JEAN-MARIE BERNARD, BELFRAGE, ANNA, KARIN, GERTRUD, LINNEA, JOENSSON, CARL, ERIK, DANIEL, ROSENQUIST, AASA, ANNICA, KRISTINA, NILSSON, KARL, MAGNUS, AYESA ALVAREZ, SUSANA, MC GOWAN, DAVID, CRAIG
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds of the Formula (I) including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof;usefulas HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient. L'invention concerne des composés de formule (I) comprenant un stéréoisomère, ou un N-oxyde, ou un sel d'addition pharmaceutiquement acceptable, ou un solvate d'addition pharmaceutiquement acceptable, ces composés étant utiles comme inhibiteurs du virus de l'hépatite C (VHC). L'invention concerne également des procédés de préparation de ces composés ainsi que des compositions pharmaceutiques les comprenant et agissant comme ingrédient actif.